This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-340-5p | ABCA1 | 1.09 | 0 | -1.41 | 0 | MirTarget | -0.2 | 0 | NA | |
2 | hsa-miR-340-5p | ABCD2 | 1.09 | 0 | -4.13 | 0 | mirMAP | -0.34 | 2.0E-5 | NA | |
3 | hsa-miR-340-5p | ABHD13 | 1.09 | 0 | -0.44 | 0 | mirMAP | -0.13 | 0 | NA | |
4 | hsa-miR-340-5p | ABI2 | 1.09 | 0 | -0.28 | 0 | mirMAP | -0.14 | 0 | NA | |
5 | hsa-miR-340-5p | ACAD11 | 1.09 | 0 | -1.05 | 0 | MirTarget | -0.11 | 0 | NA | |
6 | hsa-miR-340-5p | ACAP2 | 1.09 | 0 | -0.39 | 0 | mirMAP | -0.13 | 0 | NA | |
7 | hsa-miR-340-5p | ACER3 | 1.09 | 0 | -0.64 | 0 | MirTarget | -0.13 | 0.00024 | NA | |
8 | hsa-miR-340-5p | ADAM22 | 1.09 | 0 | -1.22 | 0 | mirMAP | -0.37 | 0 | NA | |
9 | hsa-miR-340-5p | AFF4 | 1.09 | 0 | -0.28 | 0.00153 | MirTarget; miRNATAP | -0.23 | 0 | NA | |
10 | hsa-miR-340-5p | AHCYL1 | 1.09 | 0 | -0.15 | 0.02457 | mirMAP | -0.15 | 0 | NA | |
11 | hsa-miR-340-5p | AHCYL2 | 1.09 | 0 | -0.11 | 0.19404 | mirMAP | -0.18 | 0 | NA | |
12 | hsa-miR-340-5p | AHR | 1.09 | 0 | -0.98 | 0 | mirMAP | -0.2 | 0 | NA | |
13 | hsa-miR-340-5p | AK3 | 1.09 | 0 | -0.93 | 0 | MirTarget | -0.13 | 0 | NA | |
14 | hsa-miR-340-5p | AKAP2 | 1.09 | 0 | -2.14 | 0 | mirMAP | -0.34 | 0 | NA | |
15 | hsa-miR-340-5p | AKT3 | 1.09 | 0 | -1.39 | 0 | mirMAP | -0.28 | 0 | NA | |
16 | hsa-miR-340-5p | ALCAM | 1.09 | 0 | 0.51 | 0.00106 | MirTarget | -0.21 | 1.0E-5 | NA | |
17 | hsa-miR-340-5p | ALKBH8 | 1.09 | 0 | -0.38 | 0 | mirMAP | -0.22 | 0 | NA | |
18 | hsa-miR-340-5p | ALPK3 | 1.09 | 0 | -1.48 | 0 | mirMAP | -0.2 | 0 | NA | |
19 | hsa-miR-340-5p | ALS2 | 1.09 | 0 | -0.23 | 3.0E-5 | MirTarget | -0.12 | 0 | NA | |
20 | hsa-miR-340-5p | ALX4 | 1.09 | 0 | -3.22 | 0 | mirMAP | -0.34 | 8.0E-5 | NA | |
21 | hsa-miR-340-5p | AMOT | 1.09 | 0 | -0.91 | 0 | miRNAWalker2 validate; mirMAP | -0.19 | 0 | NA | |
22 | hsa-miR-340-5p | AMOTL1 | 1.09 | 0 | -1.81 | 0 | mirMAP | -0.22 | 0 | NA | |
23 | hsa-miR-340-5p | ANKH | 1.09 | 0 | -0.31 | 0.00327 | mirMAP | -0.13 | 5.0E-5 | NA | |
24 | hsa-miR-340-5p | ANKRD26 | 1.09 | 0 | -0.11 | 0.24936 | mirMAP | -0.16 | 0 | NA | |
25 | hsa-miR-340-5p | ANKRD28 | 1.09 | 0 | -0.1 | 0.1268 | MirTarget; miRNATAP | -0.16 | 0 | NA | |
26 | hsa-miR-340-5p | ANKRD29 | 1.09 | 0 | -2.95 | 0 | miRNAWalker2 validate; MirTarget; mirMAP | -0.38 | 0 | NA | |
27 | hsa-miR-340-5p | ANKRD40 | 1.09 | 0 | -0.79 | 0 | miRNAWalker2 validate; mirMAP | -0.22 | 0 | NA | |
28 | hsa-miR-340-5p | ANO6 | 1.09 | 0 | -1.5 | 0 | mirMAP | -0.32 | 0 | NA | |
29 | hsa-miR-340-5p | ANTXR2 | 1.09 | 0 | -1.7 | 0 | mirMAP | -0.26 | 0 | NA | |
30 | hsa-miR-340-5p | APBB2 | 1.09 | 0 | -0.39 | 0.0002 | mirMAP | -0.21 | 0 | NA | |
31 | hsa-miR-340-5p | APH1B | 1.09 | 0 | -0.54 | 0 | mirMAP | -0.23 | 0 | NA | |
32 | hsa-miR-340-5p | APLN | 1.09 | 0 | 0.04 | 0.75786 | MirTarget; miRNATAP | -0.11 | 0.0174 | NA | |
33 | hsa-miR-340-5p | APPBP2 | 1.09 | 0 | -0.25 | 0.00343 | MirTarget | -0.2 | 0 | NA | |
34 | hsa-miR-340-5p | APPL1 | 1.09 | 0 | -0.29 | 1.0E-5 | miRNAWalker2 validate; MirTarget | -0.18 | 0 | NA | |
35 | hsa-miR-340-5p | AQP4 | 1.09 | 0 | -2.95 | 0 | mirMAP | -0.33 | 3.0E-5 | NA | |
36 | hsa-miR-340-5p | AR | 1.09 | 0 | -1 | 0.00094 | mirMAP | -0.59 | 0 | NA | |
37 | hsa-miR-340-5p | ARHGAP12 | 1.09 | 0 | -0.58 | 0 | miRNAWalker2 validate | -0.19 | 0 | NA | |
38 | hsa-miR-340-5p | ARHGAP19 | 1.09 | 0 | -0.97 | 0 | mirMAP | -0.18 | 0 | NA | |
39 | hsa-miR-340-5p | ARHGAP24 | 1.09 | 0 | -1.41 | 0 | mirMAP | -0.15 | 1.0E-5 | NA | |
40 | hsa-miR-340-5p | ARHGAP26 | 1.09 | 0 | -1.51 | 0 | mirMAP | -0.21 | 0 | NA | |
41 | hsa-miR-340-5p | ARHGAP32 | 1.09 | 0 | 0.43 | 9.0E-5 | mirMAP | -0.2 | 0 | NA | |
42 | hsa-miR-340-5p | ARHGAP6 | 1.09 | 0 | -1.65 | 0 | mirMAP | -0.21 | 0 | NA | |
43 | hsa-miR-340-5p | ARHGEF6 | 1.09 | 0 | -1.7 | 0 | MirTarget | -0.27 | 0 | NA | |
44 | hsa-miR-340-5p | ARID1B | 1.09 | 0 | -0.39 | 0 | MirTarget | -0.12 | 0 | NA | |
45 | hsa-miR-340-5p | ARID2 | 1.09 | 0 | 0.01 | 0.8705 | MirTarget | -0.16 | 0 | NA | |
46 | hsa-miR-340-5p | ARL10 | 1.09 | 0 | -1.27 | 0 | mirMAP | -0.28 | 0 | NA | |
47 | hsa-miR-340-5p | ARL13B | 1.09 | 0 | -0.46 | 0 | mirMAP | -0.19 | 0 | NA | |
48 | hsa-miR-340-5p | ARL4A | 1.09 | 0 | -1.62 | 0 | mirMAP | -0.11 | 0.0019 | NA | |
49 | hsa-miR-340-5p | ARL6IP5 | 1.09 | 0 | -0.45 | 0 | mirMAP | -0.1 | 0 | NA | |
50 | hsa-miR-340-5p | ARMC8 | 1.09 | 0 | -0.25 | 0 | MirTarget; mirMAP | -0.11 | 0 | NA | |
51 | hsa-miR-340-5p | ARPP19 | 1.09 | 0 | -0.25 | 0.00027 | mirMAP | -0.18 | 0 | NA | |
52 | hsa-miR-340-5p | ASXL3 | 1.09 | 0 | -2.86 | 0 | mirMAP | -0.45 | 0 | NA | |
53 | hsa-miR-340-5p | ATF1 | 1.09 | 0 | -0.23 | 3.0E-5 | MirTarget | -0.1 | 0 | NA | |
54 | hsa-miR-340-5p | ATP11B | 1.09 | 0 | -0.93 | 0 | mirMAP | -0.11 | 0.00211 | NA | |
55 | hsa-miR-340-5p | ATP2B4 | 1.09 | 0 | -1.11 | 0 | mirMAP | -0.23 | 0 | NA | |
56 | hsa-miR-340-5p | ATP7A | 1.09 | 0 | -0.47 | 0 | mirMAP | -0.2 | 0 | NA | |
57 | hsa-miR-340-5p | ATP8B1 | 1.09 | 0 | 0.58 | 0 | MirTarget | -0.23 | 0 | NA | |
58 | hsa-miR-340-5p | ATXN1L | 1.09 | 0 | -0.97 | 0 | mirMAP | -0.23 | 0 | NA | |
59 | hsa-miR-340-5p | AVL9 | 1.09 | 0 | 0.23 | 0.01367 | mirMAP | -0.14 | 0 | NA | |
60 | hsa-miR-340-5p | BACE1 | 1.09 | 0 | -0.67 | 0 | mirMAP | -0.19 | 0 | NA | |
61 | hsa-miR-340-5p | BBS10 | 1.09 | 0 | -0.8 | 0 | miRNAWalker2 validate; mirMAP | -0.24 | 0 | NA | |
62 | hsa-miR-340-5p | BBS7 | 1.09 | 0 | -0.61 | 0 | mirMAP | -0.13 | 0 | NA | |
63 | hsa-miR-340-5p | BBX | 1.09 | 0 | -0.61 | 0 | mirMAP | -0.22 | 0 | NA | |
64 | hsa-miR-340-5p | BCKDHB | 1.09 | 0 | -0.64 | 0 | mirMAP | -0.13 | 0 | NA | |
65 | hsa-miR-340-5p | BCLAF1 | 1.09 | 0 | -0.27 | 1.0E-5 | mirMAP | -0.15 | 0 | NA | |
66 | hsa-miR-340-5p | BCOR | 1.09 | 0 | 0.37 | 2.0E-5 | MirTarget | -0.12 | 1.0E-5 | NA | |
67 | hsa-miR-340-5p | BEND7 | 1.09 | 0 | -1.72 | 0 | mirMAP | -0.14 | 0.0192 | NA | |
68 | hsa-miR-340-5p | BIVM | 1.09 | 0 | -0.67 | 0 | miRNAWalker2 validate | -0.15 | 0 | NA | |
69 | hsa-miR-340-5p | BMP5 | 1.09 | 0 | -4.21 | 0 | mirMAP | -0.3 | 0.0042 | NA | |
70 | hsa-miR-340-5p | BMPR1A | 1.09 | 0 | -0.75 | 0 | MirTarget | -0.21 | 0 | NA | |
71 | hsa-miR-340-5p | BMPR2 | 1.09 | 0 | -0.62 | 0 | mirMAP | -0.23 | 0 | NA | |
72 | hsa-miR-340-5p | BMX | 1.09 | 0 | -3.75 | 0 | MirTarget | -0.33 | 2.0E-5 | NA | |
73 | hsa-miR-340-5p | BNC2 | 1.09 | 0 | -0.78 | 0 | mirMAP | -0.24 | 0 | NA | |
74 | hsa-miR-340-5p | BNIP2 | 1.09 | 0 | -0.8 | 0 | MirTarget | -0.1 | 0 | NA | |
75 | hsa-miR-340-5p | BTC | 1.09 | 0 | -1.19 | 0 | mirMAP | -0.24 | 0.00018 | NA | |
76 | hsa-miR-340-5p | BVES | 1.09 | 0 | -1.62 | 0 | MirTarget | -0.22 | 0 | NA | |
77 | hsa-miR-340-5p | C16orf45 | 1.09 | 0 | -0.55 | 0.00106 | mirMAP | -0.22 | 3.0E-5 | NA | |
78 | hsa-miR-340-5p | C1QTNF3 | 1.09 | 0 | 0.57 | 0.00057 | MirTarget | -0.15 | 0.00335 | NA | |
79 | hsa-miR-340-5p | C21orf91 | 1.09 | 0 | -0.78 | 0 | mirMAP | -0.11 | 0.00076 | NA | |
80 | hsa-miR-340-5p | C3orf58 | 1.09 | 0 | -1.12 | 0 | miRNATAP | -0.13 | 0.00051 | NA | |
81 | hsa-miR-340-5p | C3orf70 | 1.09 | 0 | -0.82 | 0 | mirMAP | -0.16 | 0.00041 | NA | |
82 | hsa-miR-340-5p | C4orf32 | 1.09 | 0 | -0.94 | 0 | mirMAP | -0.24 | 0 | NA | |
83 | hsa-miR-340-5p | C4orf36 | 1.09 | 0 | -0.43 | 0.00053 | mirMAP | -0.25 | 0 | NA | |
84 | hsa-miR-340-5p | C5orf30 | 1.09 | 0 | 0.37 | 0.00227 | mirMAP | -0.12 | 0.0015 | NA | |
85 | hsa-miR-340-5p | CACNB2 | 1.09 | 0 | -0.73 | 2.0E-5 | miRNATAP | -0.28 | 0 | NA | |
86 | hsa-miR-340-5p | CACNB4 | 1.09 | 0 | -1.55 | 0 | mirMAP | -0.16 | 0.00215 | NA | |
87 | hsa-miR-340-5p | CADM2 | 1.09 | 0 | -2.4 | 0 | MirTarget | -0.44 | 0 | NA | |
88 | hsa-miR-340-5p | CAPN7 | 1.09 | 0 | -0.37 | 0 | MirTarget | -0.19 | 0 | NA | |
89 | hsa-miR-340-5p | CASC4 | 1.09 | 0 | -0.15 | 0.04292 | MirTarget | -0.19 | 0 | NA | |
90 | hsa-miR-340-5p | CASK | 1.09 | 0 | 0.23 | 0.00547 | mirMAP | -0.1 | 5.0E-5 | NA | |
91 | hsa-miR-340-5p | CAST | 1.09 | 0 | -0.6 | 0 | miRNATAP | -0.16 | 0 | NA | |
92 | hsa-miR-340-5p | CAV1 | 1.09 | 0 | -3.35 | 0 | MirTarget | -0.38 | 0 | NA | |
93 | hsa-miR-340-5p | CBR4 | 1.09 | 0 | -0.13 | 0.12049 | MirTarget | -0.13 | 0 | NA | |
94 | hsa-miR-340-5p | CCDC126 | 1.09 | 0 | -0.21 | 0.03155 | mirMAP | -0.14 | 1.0E-5 | NA | |
95 | hsa-miR-340-5p | CCDC146 | 1.09 | 0 | -0.44 | 3.0E-5 | MirTarget | -0.1 | 0.00148 | NA | |
96 | hsa-miR-340-5p | CCDC47 | 1.09 | 0 | 0.15 | 0.05931 | miRNATAP | -0.14 | 0 | NA | |
97 | hsa-miR-340-5p | CCDC50 | 1.09 | 0 | -1.33 | 0 | mirMAP | -0.16 | 0 | NA | |
98 | hsa-miR-340-5p | CCDC82 | 1.09 | 0 | -1.57 | 0 | MirTarget | -0.1 | 0.00514 | NA | |
99 | hsa-miR-340-5p | CCL28 | 1.09 | 0 | -3.13 | 0 | mirMAP | -0.17 | 0.0367 | NA | |
100 | hsa-miR-340-5p | CCND1 | 1.09 | 0 | 0.79 | 0 | mirMAP | -0.16 | 0.00211 | NA | |
101 | hsa-miR-340-5p | CCNG2 | 1.09 | 0 | -0.15 | 0.14084 | MirTarget; mirMAP | -0.16 | 0 | 27374211 | MicroRNA 340 promotes the tumor growth of human gastric cancer by inhibiting cyclin G2; Notably alteration of miR-340 expression affected the luciferase activity of wild-type 3'-UTR of cyclin G2 CCNG2 and regulated CCNG2 abundance in gastric cancer cells indicating that CCNG2 is a direct target of miR-340; Moreover CCNG2 knockdown eradicated the effects of miR-340 silencing on gastric cancer cells |
102 | hsa-miR-340-5p | CCNT2 | 1.09 | 0 | -0.29 | 3.0E-5 | mirMAP | -0.11 | 0 | NA | |
103 | hsa-miR-340-5p | CCPG1 | 1.09 | 0 | -0.53 | 0 | MirTarget | -0.24 | 0 | NA | |
104 | hsa-miR-340-5p | CD209 | 1.09 | 0 | -2.69 | 0 | mirMAP | -0.19 | 0.00306 | NA | |
105 | hsa-miR-340-5p | CD2AP | 1.09 | 0 | 0.26 | 0.00079 | mirMAP | -0.13 | 0 | NA | |
106 | hsa-miR-340-5p | CD302 | 1.09 | 0 | -1.77 | 0 | mirMAP | -0.22 | 0 | NA | |
107 | hsa-miR-340-5p | CD44 | 1.09 | 0 | 0.06 | 0.57241 | mirMAP | -0.12 | 0.00089 | NA | |
108 | hsa-miR-340-5p | CD46 | 1.09 | 0 | 0.22 | 0.00794 | miRNAWalker2 validate; mirMAP | -0.15 | 0 | NA | |
109 | hsa-miR-340-5p | CD47 | 1.09 | 0 | -0.45 | 0 | miRNATAP | -0.12 | 0 | NA | |
110 | hsa-miR-340-5p | CD93 | 1.09 | 0 | -1.1 | 0 | mirMAP | -0.19 | 0 | NA | |
111 | hsa-miR-340-5p | CDC42EP3 | 1.09 | 0 | -1.06 | 0 | mirMAP | -0.16 | 3.0E-5 | NA | |
112 | hsa-miR-340-5p | CDH12 | 1.09 | 0 | -1.96 | 0 | MirTarget | -0.23 | 9.0E-5 | NA | |
113 | hsa-miR-340-5p | CDH6 | 1.09 | 0 | -0.97 | 0 | mirMAP | -0.25 | 0 | NA | |
114 | hsa-miR-340-5p | CDH8 | 1.09 | 0 | -1.56 | 0 | mirMAP | -0.43 | 0 | NA | |
115 | hsa-miR-340-5p | CDK12 | 1.09 | 0 | 0.2 | 0.04665 | mirMAP | -0.12 | 0.0002 | NA | |
116 | hsa-miR-340-5p | CDK6 | 1.09 | 0 | -1.03 | 0 | mirMAP | -0.12 | 0.01354 | NA | |
117 | hsa-miR-340-5p | CDON | 1.09 | 0 | -0.99 | 0 | MirTarget | -0.37 | 0 | NA | |
118 | hsa-miR-340-5p | CDYL2 | 1.09 | 0 | 0.31 | 0.04236 | mirMAP | -0.25 | 0 | NA | |
119 | hsa-miR-340-5p | CEP120 | 1.09 | 0 | -0.64 | 0 | miRNATAP | -0.18 | 0 | NA | |
120 | hsa-miR-340-5p | CEP290 | 1.09 | 0 | -0.22 | 0.01345 | MirTarget | -0.18 | 0 | NA | |
121 | hsa-miR-340-5p | CEP57 | 1.09 | 0 | -0.46 | 0 | MirTarget | -0.11 | 0 | NA | |
122 | hsa-miR-340-5p | CEP68 | 1.09 | 0 | -1.32 | 0 | MirTarget | -0.21 | 0 | NA | |
123 | hsa-miR-340-5p | CEP97 | 1.09 | 0 | 0.06 | 0.59549 | mirMAP | -0.23 | 0 | NA | |
124 | hsa-miR-340-5p | CHD6 | 1.09 | 0 | -0.27 | 0.00287 | mirMAP | -0.19 | 0 | NA | |
125 | hsa-miR-340-5p | CHD9 | 1.09 | 0 | -1.21 | 0 | mirMAP | -0.34 | 0 | NA | |
126 | hsa-miR-340-5p | CHL1 | 1.09 | 0 | -4.19 | 0 | mirMAP | -0.55 | 0 | NA | |
127 | hsa-miR-340-5p | CHM | 1.09 | 0 | -0.44 | 0 | mirMAP | -0.23 | 0 | NA | |
128 | hsa-miR-340-5p | CLDN8 | 1.09 | 0 | -2.41 | 0 | MirTarget | -0.25 | 0.01122 | NA | |
129 | hsa-miR-340-5p | CLIC4 | 1.09 | 0 | -0.6 | 0 | MirTarget | -0.13 | 0 | NA | |
130 | hsa-miR-340-5p | CLIP1 | 1.09 | 0 | -0.42 | 0 | mirMAP | -0.17 | 0 | NA | |
131 | hsa-miR-340-5p | CLIP4 | 1.09 | 0 | -2.32 | 0 | MirTarget | -0.24 | 1.0E-5 | NA | |
132 | hsa-miR-340-5p | CLMN | 1.09 | 0 | -0.54 | 0 | mirMAP | -0.1 | 0.00161 | NA | |
133 | hsa-miR-340-5p | CLOCK | 1.09 | 0 | -0.44 | 0.00109 | MirTarget; mirMAP | -0.29 | 0 | NA | |
134 | hsa-miR-340-5p | CMTM6 | 1.09 | 0 | 0.13 | 0.07841 | mirMAP | -0.13 | 0 | NA | |
135 | hsa-miR-340-5p | CNKSR2 | 1.09 | 0 | -3.5 | 0 | mirMAP; miRNATAP | -0.25 | 0.00122 | NA | |
136 | hsa-miR-340-5p | CNOT4 | 1.09 | 0 | -0.16 | 0.001 | mirMAP | -0.1 | 0 | NA | |
137 | hsa-miR-340-5p | CNRIP1 | 1.09 | 0 | -1.67 | 0 | mirMAP | -0.17 | 0 | NA | |
138 | hsa-miR-340-5p | CNTN4 | 1.09 | 0 | -1.68 | 0 | mirMAP | -0.44 | 0 | NA | |
139 | hsa-miR-340-5p | COBLL1 | 1.09 | 0 | -1.51 | 0 | mirMAP | -0.32 | 0 | NA | |
140 | hsa-miR-340-5p | COG6 | 1.09 | 0 | -0.3 | 3.0E-5 | mirMAP | -0.19 | 0 | NA | |
141 | hsa-miR-340-5p | COL4A3BP | 1.09 | 0 | -1.02 | 0 | MirTarget | -0.25 | 0 | NA | |
142 | hsa-miR-340-5p | CPD | 1.09 | 0 | -0.24 | 0.02078 | mirMAP | -0.24 | 0 | NA | |
143 | hsa-miR-340-5p | CPEB3 | 1.09 | 0 | -0.8 | 0 | mirMAP | -0.25 | 0 | NA | |
144 | hsa-miR-340-5p | CPM | 1.09 | 0 | -1.87 | 0 | mirMAP | -0.19 | 2.0E-5 | NA | |
145 | hsa-miR-340-5p | CREB1 | 1.09 | 0 | -0.39 | 0 | MirTarget | -0.14 | 0 | NA | |
146 | hsa-miR-340-5p | CREB5 | 1.09 | 0 | -2.35 | 0 | mirMAP | -0.29 | 0 | NA | |
147 | hsa-miR-340-5p | CRY2 | 1.09 | 0 | -1.2 | 0 | miRNAWalker2 validate | -0.2 | 0 | NA | |
148 | hsa-miR-340-5p | CRYZ | 1.09 | 0 | -0.15 | 0.08389 | mirMAP | -0.12 | 1.0E-5 | NA | |
149 | hsa-miR-340-5p | CSDE1 | 1.09 | 0 | -0.7 | 0 | miRNAWalker2 validate; mirMAP; miRNATAP | -0.12 | 0 | NA | |
150 | hsa-miR-340-5p | CSRNP3 | 1.09 | 0 | -3.02 | 0 | mirMAP | -0.63 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | POSITIVE REGULATION OF GENE EXPRESSION | 119 | 1733 | 2.6e-10 | 1.21e-06 |
2 | REGULATION OF CELL DIFFERENTIATION | 104 | 1492 | 1.875e-09 | 4.363e-06 |
3 | INTRACELLULAR SIGNAL TRANSDUCTION | 106 | 1572 | 7.752e-09 | 8e-06 |
4 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 111 | 1672 | 7.674e-09 | 8e-06 |
5 | CELL DEVELOPMENT | 98 | 1426 | 1.203e-08 | 8e-06 |
6 | TISSUE DEVELOPMENT | 103 | 1518 | 9.436e-09 | 8e-06 |
7 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 116 | 1784 | 1.079e-08 | 8e-06 |
8 | REGULATION OF GTPASE ACTIVITY | 57 | 673 | 2.086e-08 | 1.213e-05 |
9 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 115 | 1805 | 3.853e-08 | 1.992e-05 |
10 | CELL GROWTH | 21 | 135 | 4.854e-08 | 2.258e-05 |
11 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 62 | 788 | 7.434e-08 | 2.882e-05 |
12 | CIRCULATORY SYSTEM DEVELOPMENT | 62 | 788 | 7.434e-08 | 2.882e-05 |
13 | CELL PROJECTION ORGANIZATION | 68 | 902 | 8.753e-08 | 3.133e-05 |
14 | LOCOMOTION | 79 | 1114 | 1.004e-07 | 3.336e-05 |
15 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 73 | 1008 | 1.413e-07 | 4.383e-05 |
16 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 105 | 1656 | 2.095e-07 | 5.416e-05 |
17 | GROWTH | 39 | 410 | 2.036e-07 | 5.416e-05 |
18 | RESPONSE TO GROWTH FACTOR | 43 | 475 | 1.945e-07 | 5.416e-05 |
19 | DEVELOPMENTAL GROWTH | 34 | 333 | 2.379e-07 | 5.827e-05 |
20 | TISSUE MORPHOGENESIS | 46 | 533 | 2.917e-07 | 5.942e-05 |
21 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 111 | 1791 | 2.836e-07 | 5.942e-05 |
22 | NEUROGENESIS | 92 | 1402 | 2.937e-07 | 5.942e-05 |
23 | REGULATION OF CELL DEVELOPMENT | 63 | 836 | 2.709e-07 | 5.942e-05 |
24 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 58 | 750 | 3.535e-07 | 6.854e-05 |
25 | REGULATION OF TRANSPORT | 111 | 1804 | 4.065e-07 | 7.566e-05 |
26 | PROTEIN PHOSPHORYLATION | 68 | 944 | 4.717e-07 | 8.442e-05 |
27 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 44 | 513 | 6.274e-07 | 0.0001081 |
28 | RESPONSE TO ENDOGENOUS STIMULUS | 93 | 1450 | 6.902e-07 | 0.0001147 |
29 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 78 | 1152 | 7.719e-07 | 0.0001239 |
30 | REGULATION OF NEURON DIFFERENTIATION | 46 | 554 | 8.666e-07 | 0.0001263 |
31 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 84 | 1275 | 8.64e-07 | 0.0001263 |
32 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 58 | 771 | 8.686e-07 | 0.0001263 |
33 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 70 | 1004 | 1.046e-06 | 0.0001475 |
34 | CELL PART MORPHOGENESIS | 50 | 633 | 1.26e-06 | 0.0001629 |
35 | REGULATION OF HYDROLASE ACTIVITY | 86 | 1327 | 1.243e-06 | 0.0001629 |
36 | DEVELOPMENTAL CELL GROWTH | 14 | 77 | 1.216e-06 | 0.0001629 |
37 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 53 | 689 | 1.344e-06 | 0.000169 |
38 | REGULATION OF CIRCADIAN RHYTHM | 16 | 103 | 1.93e-06 | 0.0002363 |
39 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 76 | 1142 | 2.062e-06 | 0.000246 |
40 | NEURON PROJECTION MORPHOGENESIS | 36 | 402 | 2.469e-06 | 0.0002872 |
41 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 94 | 1518 | 2.705e-06 | 0.0003052 |
42 | RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 19 | 144 | 2.755e-06 | 0.0003052 |
43 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 66 | 957 | 3.118e-06 | 0.0003311 |
44 | HEAD DEVELOPMENT | 53 | 709 | 3.131e-06 | 0.0003311 |
45 | CELLULAR COMPONENT MORPHOGENESIS | 63 | 900 | 3.263e-06 | 0.0003374 |
46 | NEURON PROJECTION EXTENSION | 11 | 53 | 4.402e-06 | 0.0004358 |
47 | REGULATION OF CELLULAR PROTEIN LOCALIZATION | 44 | 552 | 4.357e-06 | 0.0004358 |
48 | POSITIVE REGULATION OF CELL PROLIFERATION | 58 | 814 | 4.743e-06 | 0.0004504 |
49 | RHYTHMIC PROCESS | 29 | 298 | 4.722e-06 | 0.0004504 |
50 | CIRCADIAN RHYTHM | 18 | 137 | 5.324e-06 | 0.0004955 |
51 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 33 | 368 | 6.259e-06 | 0.000571 |
52 | NEURON PROJECTION DEVELOPMENT | 43 | 545 | 7.222e-06 | 0.0006356 |
53 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 97 | 1618 | 7.24e-06 | 0.0006356 |
54 | REGULATION OF CELL MATRIX ADHESION | 14 | 90 | 8.247e-06 | 0.0007106 |
55 | REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 27 | 278 | 1.034e-05 | 0.0008588 |
56 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 15 | 104 | 1.023e-05 | 0.0008588 |
57 | REGULATION OF CELL SIZE | 20 | 172 | 1.069e-05 | 0.000873 |
58 | NEURON DEVELOPMENT | 50 | 687 | 1.234e-05 | 0.0009899 |
59 | REGULATION OF CELL PROLIFERATION | 90 | 1496 | 1.401e-05 | 0.001105 |
60 | POSITIVE REGULATION OF LOCOMOTION | 35 | 420 | 1.631e-05 | 0.001224 |
61 | SKELETAL SYSTEM DEVELOPMENT | 37 | 455 | 1.618e-05 | 0.001224 |
62 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 27 | 285 | 1.622e-05 | 0.001224 |
63 | EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 16 | 122 | 1.795e-05 | 0.001326 |
64 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 30 | 337 | 1.882e-05 | 0.001347 |
65 | REGULATION OF CELLULAR COMPONENT SIZE | 30 | 337 | 1.882e-05 | 0.001347 |
66 | CELL MOTILITY | 57 | 835 | 2.006e-05 | 0.001393 |
67 | LOCALIZATION OF CELL | 57 | 835 | 2.006e-05 | 0.001393 |
68 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 45 | 609 | 2.32e-05 | 0.001587 |
69 | PROTEIN UBIQUITINATION | 46 | 629 | 2.438e-05 | 0.001597 |
70 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 55 | 801 | 2.388e-05 | 0.001597 |
71 | REGULATION OF CELL ADHESION | 46 | 629 | 2.438e-05 | 0.001597 |
72 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 18 | 154 | 2.717e-05 | 0.001688 |
73 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 84 | 1395 | 2.686e-05 | 0.001688 |
74 | HEART DEVELOPMENT | 37 | 466 | 2.72e-05 | 0.001688 |
75 | PHOSPHORYLATION | 76 | 1228 | 2.687e-05 | 0.001688 |
76 | EPITHELIUM DEVELOPMENT | 62 | 945 | 2.873e-05 | 0.001759 |
77 | NEGATIVE REGULATION OF CELL COMMUNICATION | 74 | 1192 | 3.115e-05 | 0.001882 |
78 | REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 22 | 218 | 3.734e-05 | 0.002228 |
79 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 66 | 1036 | 3.918e-05 | 0.002269 |
80 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 89 | 1517 | 3.998e-05 | 0.002269 |
81 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 66 | 1036 | 3.918e-05 | 0.002269 |
82 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 14 | 103 | 3.96e-05 | 0.002269 |
83 | REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 22 | 220 | 4.291e-05 | 0.002406 |
84 | ORGAN MORPHOGENESIS | 56 | 841 | 4.713e-05 | 0.002611 |
85 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 33 | 408 | 5.101e-05 | 0.002792 |
86 | ORGAN GROWTH | 11 | 68 | 5.24e-05 | 0.002835 |
87 | REGULATION OF DEVELOPMENTAL GROWTH | 26 | 289 | 5.581e-05 | 0.002918 |
88 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 52 | 767 | 5.544e-05 | 0.002918 |
89 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 81 | 1360 | 5.49e-05 | 0.002918 |
90 | REGULATION OF OSSIFICATION | 19 | 178 | 5.829e-05 | 0.003014 |
91 | EMBRYONIC MORPHOGENESIS | 40 | 539 | 5.955e-05 | 0.003045 |
92 | REGULATION OF CELL PROJECTION ORGANIZATION | 41 | 558 | 6.029e-05 | 0.003049 |
93 | REGULATION OF PROTEIN MODIFICATION PROCESS | 97 | 1710 | 6.417e-05 | 0.003177 |
94 | GLAND DEVELOPMENT | 32 | 395 | 6.401e-05 | 0.003177 |
95 | MUSCLE TISSUE DEVELOPMENT | 25 | 275 | 6.511e-05 | 0.003189 |
96 | AXON EXTENSION | 8 | 37 | 6.601e-05 | 0.0032 |
97 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 57 | 872 | 6.691e-05 | 0.00321 |
98 | MUSCLE STRUCTURE DEVELOPMENT | 34 | 432 | 6.786e-05 | 0.003222 |
99 | PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 57 | 873 | 6.902e-05 | 0.003244 |
100 | EMBRYO DEVELOPMENT | 58 | 894 | 7.099e-05 | 0.003247 |
101 | VASCULATURE DEVELOPMENT | 36 | 469 | 6.999e-05 | 0.003247 |
102 | NEURON DIFFERENTIATION | 57 | 874 | 7.119e-05 | 0.003247 |
103 | REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 31 | 381 | 7.652e-05 | 0.003457 |
104 | MORPHOGENESIS OF AN EPITHELIUM | 32 | 400 | 8.116e-05 | 0.003631 |
105 | NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 12 | 84 | 8.529e-05 | 0.00378 |
106 | NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 47 | 684 | 9.166e-05 | 0.004023 |
107 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 54 | 823 | 9.434e-05 | 0.004103 |
108 | PALATE DEVELOPMENT | 12 | 85 | 9.589e-05 | 0.004131 |
109 | TUBE DEVELOPMENT | 40 | 552 | 9.968e-05 | 0.004141 |
110 | UROGENITAL SYSTEM DEVELOPMENT | 26 | 299 | 9.795e-05 | 0.004141 |
111 | NEGATIVE CHEMOTAXIS | 8 | 39 | 9.829e-05 | 0.004141 |
112 | REGULATION OF CELL MORPHOGENESIS | 40 | 552 | 9.968e-05 | 0.004141 |
113 | NEGATIVE REGULATION OF ORGAN GROWTH | 6 | 21 | 0.0001047 | 0.004313 |
114 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 37 | 498 | 0.000109 | 0.00445 |
115 | PROTEIN LOCALIZATION | 100 | 1805 | 0.0001198 | 0.004848 |
116 | STRIATED MUSCLE CELL DIFFERENTIATION | 18 | 173 | 0.0001257 | 0.005043 |
117 | MUSCLE CELL DIFFERENTIATION | 22 | 237 | 0.0001296 | 0.005156 |
118 | FOREBRAIN DEVELOPMENT | 29 | 357 | 0.0001327 | 0.005187 |
119 | NEURON PROJECTION GUIDANCE | 20 | 205 | 0.0001323 | 0.005187 |
120 | PROTEIN CATABOLIC PROCESS | 41 | 579 | 0.0001348 | 0.005228 |
121 | SECOND MESSENGER MEDIATED SIGNALING | 17 | 160 | 0.0001488 | 0.005721 |
122 | CELLULAR MACROMOLECULE LOCALIZATION | 73 | 1234 | 0.0001598 | 0.006043 |
123 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 49 | 740 | 0.0001595 | 0.006043 |
124 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 107 | 1977 | 0.0001676 | 0.006288 |
125 | DENDRITE MORPHOGENESIS | 8 | 42 | 0.0001703 | 0.00634 |
126 | REGULATION OF ANATOMICAL STRUCTURE SIZE | 35 | 472 | 0.0001722 | 0.006359 |
127 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 57 | 905 | 0.0001785 | 0.006541 |
128 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 101 | 1848 | 0.0001827 | 0.00664 |
129 | BLOOD VESSEL MORPHOGENESIS | 29 | 364 | 0.000185 | 0.006673 |
130 | SENSORY ORGAN DEVELOPMENT | 36 | 493 | 0.0001887 | 0.006754 |
131 | REGULATION OF PROTEIN LOCALIZATION | 59 | 950 | 0.0001996 | 0.007088 |
132 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 39 | 554 | 0.0002198 | 0.007689 |
133 | NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 15 | 135 | 0.0002194 | 0.007689 |
134 | REGULATION OF CELL JUNCTION ASSEMBLY | 10 | 68 | 0.0002573 | 0.008738 |
135 | REGULATION OF PROTEIN IMPORT | 18 | 183 | 0.0002548 | 0.008738 |
136 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 62 | 1021 | 0.0002529 | 0.008738 |
137 | POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 10 | 68 | 0.0002573 | 0.008738 |
138 | TAXIS | 34 | 464 | 0.0002645 | 0.008917 |
139 | REGULATION OF CYTOSKELETON ORGANIZATION | 36 | 502 | 0.0002672 | 0.008944 |
140 | PALLIUM DEVELOPMENT | 16 | 153 | 0.0002767 | 0.009179 |
141 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 60 | 983 | 0.0002781 | 0.009179 |
142 | CIRCADIAN REGULATION OF GENE EXPRESSION | 9 | 57 | 0.0003011 | 0.009867 |
143 | CELLULAR RESPONSE TO STRESS | 87 | 1565 | 0.0003067 | 0.009981 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | MOLECULAR FUNCTION REGULATOR | 90 | 1353 | 2.213e-07 | 0.0001028 |
2 | ENZYME BINDING | 109 | 1737 | 1.996e-07 | 0.0001028 |
3 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 78 | 1199 | 3.517e-06 | 0.001089 |
4 | ENZYME REGULATOR ACTIVITY | 65 | 959 | 6.542e-06 | 0.001519 |
5 | NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 30 | 329 | 1.184e-05 | 0.0022 |
6 | ENZYME ACTIVATOR ACTIVITY | 38 | 471 | 1.489e-05 | 0.002305 |
7 | PROTEIN KINASE ACTIVITY | 47 | 640 | 1.791e-05 | 0.002377 |
8 | KINASE ACTIVITY | 57 | 842 | 2.542e-05 | 0.002624 |
9 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 36 | 445 | 2.346e-05 | 0.002624 |
10 | UBIQUITIN LIKE PROTEIN TRANSFERASE ACTIVITY | 34 | 420 | 3.875e-05 | 0.0036 |
11 | PHOSPHATASE BINDING | 18 | 162 | 5.354e-05 | 0.004145 |
12 | DOUBLE STRANDED DNA BINDING | 52 | 764 | 5.01e-05 | 0.004145 |
13 | SEQUENCE SPECIFIC DNA BINDING | 64 | 1037 | 0.0001282 | 0.009162 |
14 | CYTOSKELETAL PROTEIN BINDING | 53 | 819 | 0.0001547 | 0.009582 |
15 | REGULATORY REGION NUCLEIC ACID BINDING | 53 | 818 | 0.0001501 | 0.009582 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL PROJECTION | 118 | 1786 | 3.129e-09 | 1.828e-06 |
2 | PLASMA MEMBRANE REGION | 68 | 929 | 2.63e-07 | 7.681e-05 |
3 | MEMBRANE REGION | 78 | 1134 | 4.163e-07 | 8.104e-05 |
4 | CYTOSKELETON | 117 | 1967 | 1.052e-06 | 0.0001536 |
5 | CENTROSOME | 41 | 487 | 2.421e-06 | 0.0002827 |
6 | NEURON PART | 81 | 1265 | 4.113e-06 | 0.0004003 |
7 | CELL LEADING EDGE | 32 | 350 | 5.781e-06 | 0.0004823 |
8 | NEURON PROJECTION | 64 | 942 | 7.159e-06 | 0.0005226 |
9 | APICAL JUNCTION COMPLEX | 17 | 128 | 8.345e-06 | 0.0005415 |
10 | GOLGI APPARATUS | 88 | 1445 | 1.109e-05 | 0.0006477 |
11 | CELL PROJECTION PART | 63 | 946 | 1.572e-05 | 0.0008345 |
12 | SYNAPSE | 53 | 754 | 1.784e-05 | 0.0008681 |
13 | CELL JUNCTION | 71 | 1151 | 5.544e-05 | 0.00249 |
14 | EXCITATORY SYNAPSE | 20 | 197 | 7.64e-05 | 0.003187 |
15 | RUFFLE | 17 | 156 | 0.000109 | 0.004243 |
16 | APICAL PART OF CELL | 29 | 361 | 0.0001607 | 0.005637 |
17 | MICROTUBULE ORGANIZING CENTER | 43 | 623 | 0.0001641 | 0.005637 |
18 | CELL CELL JUNCTION | 30 | 383 | 0.0001939 | 0.006132 |
19 | SYNAPTIC MEMBRANE | 23 | 261 | 0.0001995 | 0.006132 |
20 | CELL SURFACE | 49 | 757 | 0.0002709 | 0.007912 |
21 | LAMELLIPODIUM | 17 | 172 | 0.0003536 | 0.009834 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | cGMP_PKG_signaling_pathway_hsa04022 | 20 | 163 | 4.725e-06 | 0.0002457 | |
2 | Cellular_senescence_hsa04218 | 18 | 160 | 4.541e-05 | 0.001181 | |
3 | Apelin_signaling_pathway_hsa04371 | 16 | 137 | 7.56e-05 | 0.00131 | |
4 | Focal_adhesion_hsa04510 | 19 | 199 | 0.0002549 | 0.003314 | |
5 | TGF_beta_signaling_pathway_hsa04350 | 11 | 84 | 0.0003638 | 0.003784 | |
6 | Gap_junction_hsa04540 | 11 | 88 | 0.0005457 | 0.00473 | |
7 | Hippo_signaling_pathway_hsa04390 | 15 | 154 | 0.0008959 | 0.006656 | |
8 | Autophagy_animal_hsa04140 | 13 | 128 | 0.001316 | 0.008557 | |
9 | FoxO_signaling_pathway_hsa04068 | 13 | 132 | 0.001742 | 0.01007 | |
10 | MAPK_signaling_pathway_hsa04010 | 22 | 295 | 0.002448 | 0.01273 | |
11 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 13 | 139 | 0.002758 | 0.01304 | |
12 | Phosphatidylinositol_signaling_system_hsa04070 | 10 | 99 | 0.004761 | 0.02063 | |
13 | mTOR_signaling_pathway_hsa04150 | 13 | 151 | 0.005592 | 0.02237 | |
14 | Tight_junction_hsa04530 | 14 | 170 | 0.006092 | 0.02263 | |
15 | Regulation_of_actin_cytoskeleton_hsa04810 | 16 | 208 | 0.00674 | 0.02336 | |
16 | Oocyte_meiosis_hsa04114 | 11 | 124 | 0.008346 | 0.02713 | |
17 | Hedgehog_signaling_pathway_hsa04340 | 6 | 47 | 0.008885 | 0.02718 | |
18 | PI3K_Akt_signaling_pathway_hsa04151 | 23 | 352 | 0.009691 | 0.028 | |
19 | Wnt_signaling_pathway_hsa04310 | 12 | 146 | 0.0108 | 0.02955 | |
20 | AMPK_signaling_pathway_hsa04152 | 10 | 121 | 0.01834 | 0.04769 | |
21 | Calcium_signaling_pathway_hsa04020 | 13 | 182 | 0.02385 | 0.05907 | |
22 | Sphingolipid_signaling_pathway_hsa04071 | 9 | 118 | 0.03833 | 0.0906 | |
23 | p53_signaling_pathway_hsa04115 | 6 | 68 | 0.04635 | 0.1048 | |
24 | Endocytosis_hsa04144 | 15 | 244 | 0.05055 | 0.1095 | |
25 | Cell_adhesion_molecules_.CAMs._hsa04514 | 10 | 145 | 0.05349 | 0.1113 | |
26 | Adherens_junction_hsa04520 | 6 | 72 | 0.05833 | 0.1167 | |
27 | VEGF_signaling_pathway_hsa04370 | 5 | 59 | 0.07593 | 0.1462 | |
28 | Jak_STAT_signaling_pathway_hsa04630 | 10 | 162 | 0.09554 | 0.1714 | |
29 | ECM_receptor_interaction_hsa04512 | 6 | 82 | 0.09564 | 0.1714 | |
30 | Hippo_signaling_pathway_multiple_species_hsa04392 | 3 | 29 | 0.0989 | 0.1714 | |
31 | ErbB_signaling_pathway_hsa04012 | 6 | 85 | 0.1088 | 0.1826 | |
32 | Cytokine_cytokine_receptor_interaction_hsa04060 | 14 | 270 | 0.1593 | 0.2588 | |
33 | Rap1_signaling_pathway_hsa04015 | 11 | 206 | 0.1712 | 0.2698 | |
34 | Ras_signaling_pathway_hsa04014 | 12 | 232 | 0.1842 | 0.2818 | |
35 | Phospholipase_D_signaling_pathway_hsa04072 | 8 | 146 | 0.2006 | 0.298 | |
36 | Mitophagy_animal_hsa04137 | 4 | 65 | 0.2399 | 0.3466 | |
37 | HIF_1_signaling_pathway_hsa04066 | 5 | 100 | 0.3402 | 0.4685 | |
38 | Cell_cycle_hsa04110 | 6 | 124 | 0.3424 | 0.4685 | |
39 | cAMP_signaling_pathway_hsa04024 | 9 | 198 | 0.3522 | 0.4697 | |
40 | Peroxisome_hsa04146 | 4 | 83 | 0.3964 | 0.5093 | |
41 | TNF_signaling_pathway_hsa04668 | 5 | 108 | 0.4016 | 0.5093 | |
42 | Apoptosis_hsa04210 | 6 | 138 | 0.4388 | 0.5433 | |
43 | ABC_transporters_hsa02010 | 2 | 45 | 0.5207 | 0.629 | |
44 | Phagosome_hsa04145 | 6 | 152 | 0.5323 | 0.629 | |
45 | Notch_signaling_pathway_hsa04330 | 2 | 48 | 0.5557 | 0.6422 | |
46 | NF_kappa_B_signaling_pathway_hsa04064 | 2 | 95 | 0.8849 | 0.979 | |
47 | Necroptosis_hsa04217 | 3 | 164 | 0.954 | 1 | |
48 | Neuroactive_ligand_receptor_interaction_hsa04080 | 6 | 278 | 0.9588 | 1 |